Conduct protein analysis services in support of cancer research
Closed Solicitation Posted
- Solicitation number
- 36C24526Q0565
- Agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Washington, District of Columbia 20422, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Health Administration, Veterans Integrated Service Network 5, seeks protein analysis services in support of a longitudinal cancer research study, with proposals due June 26, 2026 at 1:00 PM EDT and questions due June 23, 2026 at 11:00 AM EST.
Place of performance is Washington, DC. The procurement is unrestricted and uses a Firm Fixed Price contract structure. The contractor will conduct high-throughput proteomic analysis using the SomaLogic SomaScan platform exclusively on coded frozen plasma aliquots from Veterans with metastatic hormone-sensitive prostate cancer and metastatic castration-resistant prostate cancer. Work includes CLIA-certified sample processing, execution of the SomaScan 11K assay to quantify up to 11,000 unique proteins per sample, and delivery of comprehensive data output in ADAT file format with detailed quality reports within three weeks of batch receipt. The contract period is one base year (July 17, 2026 through July 16, 2027) plus one optional year. The NAICS code is 541715, Research and Development in the Physical, Engineering, and Life Sciences. The PSC code is AN11, Health R&D Services. Monthly invoices will be submitted in arrears via electronic submission. The contracting officer is Veronica B. Dillard (veronica.dillard@va.gov). The contracting office is Network Contracting Office 5 in Linthicum, Maryland.
Notice text
AI-Guided Blood Proteomics for Treatment Optimization in Veterans with Metastatic Prostate Cancer.The Washington DC VA Medical Center (DC VAMC) is conducting a longitudinal study enrolling Veterans with metastatic hormone-sensitive prostate cancer (mHSPC) and metastatic castration-resistant prostate cancer (mCRPC). Serial peripheral blood specimens are collected at predefined timepoints before, during, and after treatment.
Files
| File | Type | Posted |
|---|---|---|
| 36C24526Q0565.pdf | ||
| Wage Determination No 2015-4281.pdf | ||
| 36C24526Q0565_1.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Veteran Decedent Memorial Data/Information Analysis & Visualization | VA Technology Acquisition Center | No set-aside | |
| 6550--Cepheid GeneXpert Testing Supplies | Veterans Integrated Service Network 5 | No set-aside | |
| Q301--Reference and Esoteric Laboratory Testing | Veterans Integrated Service Network 2 | No set-aside | |
| 6550--Optilite analyzer reagents | Veterans Integrated Service Network 22 | No set-aside | |
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity